Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Sethi JM, Rochester CL: Smoking and chronic obstructive pulmonary disease
Wang H, Nie J, Li P, Zhang X, Wang Y, Zhang W, et al
Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders: Proceedings of a Workshop
With the rise of GLP-1 receptor agonists, which were originally developed for diabetes treatment, they are now recognised for their ability to regulate appetite, reduce food cravings, and promote significant weight loss when combined with lifestyle changes
US$ 3510.00
Sold : Login>>
